Subcutaneous Interferon-β-1a: New Formulation

ISSN： 1172-7047

Source： CNS Drugs, Vol.21, Iss.10, 2007-01, pp. : 871-876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subcutaneous Recombinant Interferon-β-1a (Rebif®): A Review of its Use in the Treatment of Relapsing Multiple Sclerosis

By Sanford Mark Lyseng-Williamson Katherine A.

Drugs, Vol. 71, Iss. 14, 2011-10 ,pp. : 1865-1891

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum Wang Shan Gottesman Malcolm

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β-1a: Pancreatitis: case report

Reactions Weekly, Vol. 1, Iss. 1424, 2012-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

Interferon-β-1a: Panniculitis: case report

Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Interferon-β-1a: Hypersensitivity: case report

Reactions Weekly, Vol. 1, Iss. 1285, 2010-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite